Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. The company recently learned that the “Adalimumab Injection” drug registration and marketing license application from Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd., the company's holding subsidiary, was accepted by the State Drug Administration and received a “Notice of Acceptance”.

Zhitongcaijing · 06/10 08:49
Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. The company recently learned that the “Adalimumab Injection” drug registration and marketing license application from Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd., the company's holding subsidiary, was accepted by the State Drug Administration and received a “Notice of Acceptance”.